105 Laurel Creek Rd. SE Suite 1 Calhoun, GA 30701
(706) 749-4810
Monday - Thursday: 8:00 - 6:00 Friday : 8:00 - 12:00 Saturday & Sunday: CLOSED
Retatrutide
Advanced
Weight Loss
Appetite
Control
Metabolic
Support
Blood Sugar
Balance
Retatrutide for Weight Loss
Retatrutide is a groundbreaking investigational peptide developed by Eli Lilly and Company, currently in Phase 3 clinical trials for the treatment of obesity and metabolic disorders. This triple agonist compound targets the GLP-1, GIP, and glucagon receptors simultaneously, influencing multiple metabolic pathways at once. Its unique mechanism of action sets it apart from other weight loss treatments, offering the potential for superior metabolic health and more effective weight management.
Retatrutide is not yet FDA approved and is currently available only through clinical trials. Alpha Wellness Lab is actively monitoring its regulatory progress and plans to offer this therapy once it becomes available for prescription.
What Is Retatrutide and How Does It Work?
Retatrutide works by activating three critical hormonal pathways at the same time
GIP Receptor Agonism
Strengthens insulin release and plays a role in lipid metabolism, helping the body use energy more efficiently.
GLP-1 Receptor Agonism
Improves insulin secretion when blood glucose is elevated, reduces glucagon output, and slows gastric emptying. Together, these effects support better blood sugar control and greater feelings of fullness.
Glucagon Receptor Agonism
Raises basal metabolic rate and encourages fat breakdown, directly supporting weight reduction.
By acting on all three receptor pathways, Retatrutide delivers broader metabolic benefits than single agonist therapies like semaglutide or dual agonist options like tirzepatide.
How Retatrutide Stacks Up Against Other Weight Loss Medications
Retatrutide has shown superior results compared to currently available weight loss medications. In a review of clinical trial data involving nearly 15,500 participants, Retatrutide produced average weight loss of up to 22% over approximately 11 months, significantly outperforming the roughly 14% weight loss achieved with semaglutide (the active ingredient in Ozempic and Wegovy) over a longer 15 month timeframe. More recently, Phase 3 TRIUMPH-4 trial results released in December 2025 showed patients achieving an average of 28.7% body weight reduction at 68 weeks, the highest ever recorded in an obesity clinical trial.
Its action on the glucagon receptor provides additional advantages beyond weight loss alone, including increased energy expenditure and enhanced fat oxidation, making it a more complete option for individuals looking for total metabolic improvement.
What Makes Retatrutide Different
Real, Lasting Weight Loss
Clinical trials showed participants lost over 24% of body weight, with results continuing to improve over time.Better Blood Sugar & Metabolism
Supports blood sugar control, reduces insulin resistance, and improves overall metabolic health.Stronger Appetite Control
Helps reduce cravings and increase fullness, making healthy eating easier and more sustainable.Heart & Liver Health Support
May improve blood pressure, cholesterol, and liver fat levels for better long-term wellness.Burn More Fat Naturally
Supports fat burning and energy expenditure, not just appetite suppression.
What Are the Side Effects?
While Retatrutide has delivered impressive results in clinical trials, some participants have reported side effects, including
Gastrointestinal Issues
Nausea, vomiting, diarrhea, or constipation, most common during the initial weeks of treatment and typically mild.
Fatigue
Some individuals report feeling more tired than usual, particularly early in the treatment process.
Low Blood Sugar
More likely in patients already taking other glucose lowering medications.
Injection Site Reactions
Temporary redness or swelling at the injection site, usually resolving quickly.
Skin Sensitivity
About 21% of patients on the highest dose experienced skin tingling or tenderness, a side effect unique to Retatrutide.
These side effects generally diminish as the body adjusts to the medication. As with any treatment, a thorough medical evaluation is essential to weigh the potential risks and benefits for each individual.
Why Retatrutide Could Change Everything About Weight Loss
Obesity remains one of the most pressing public health challenges, and the need for effective, lasting treatment options has never been greater. Retatrutide's ability to drive substantial weight loss while simultaneously improving metabolic, cardiovascular, and liver health positions it as a potential game changer for individuals who have struggled with traditional weight loss methods. Its multi action mechanism means that weight loss is not only effective but sustainable.
Your Next Step Starts at Alpha Wellness Lab
Alpha Wellness Lab provides expert medical guidance for individuals seeking advanced, professional supervised weight loss solutions. While Retatrutide is not yet available for prescription, our team is actively tracking its progress through the FDA approval process and is prepared to offer this therapy as soon as it becomes available.
In the meantime, our specialists develop personalized treatment plans using today's best available therapies, including FDA approved GLP-1 and dual agonist options, with ongoing supervision to optimize results and minimize side effects. When Retatrutide reaches the market, patients already in our care will be first to benefit.
The Bottom Line
Retatrutide's potential to promote substantial weight loss, regulate blood sugar, improve cardiovascular markers, and increase energy expenditure positions it as one of the most promising weight loss therapies on the horizon. Phase 3 trials are ongoing and will provide further insight into its long term safety and efficacy, but current evidence suggests this treatment could set a new standard in medical weight management.
Common Questions
How is Retatrutide given and how fast does it work?
Retatrutide is delivered as a once weekly injection just under the skin, with a typical starting dose of 0.5 mg. Clinical studies show that metabolic improvements can begin within the first few weeks, with significant weight loss developing progressively over several months.
Is Retatrutide safe to use long term?
Long term safety data is still being collected through ongoing Phase 3 clinical trials. Early trial results show that patients tolerate the medication well and that its efficacy is strong. Upcoming studies will provide more comprehensive long term safety information.
Do I need a prescription?
Yes. Retatrutide is an investigational drug that requires medical supervision. It is currently only accessible through authorized clinical trials and is not yet available by prescription.
Can anyone with obesity use this therapy?
Not necessarily. A thorough medical evaluation is needed to determine whether this treatment is appropriate based on an individual's health history, existing conditions, and current medications.
What can I do now while Retatrutide is still in trials?
Alpha Wellness Lab offers professional supervised weight loss programs using FDA approved therapies available today. Starting now means building a health baseline, establishing care, and being in the strongest position to transition to Retatrutide when it becomes an option.
DISCLAIMER: Some of the services provided have not been evaluated by the Food and Drug Administration. These products may
not be intended to diagnose, treat, cure, or prevent any disease. The material on this website is provided for informational
purposes only and is not medical advice. Always consult your medical provider before beginning any therapy program.
FOLLOW US
COMPANY
CUSTOMER CARE
LEGAL
©2026 by Alpha Wellness Lab. All rights reserved
Disclaimer: Retatrutide (LY3437943) is an investigational medication developed by Eli Lilly and Company. It has not been approved by the U.S. Food and Drug Administration (FDA) for any indication. All clinical data referenced on this page is sourced from published peer reviewed studies and publicly reported trial results. This content is for educational purposes only and does not constitute medical advice, a diagnosis, or an offer to prescribe or administer any investigational drug. Consult a licensed healthcare provider regarding your treatment options.